Effects of ritonavir-boosted darunavirvs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2008.00690.x/fullpdf
Reference40 articles.
1. 1 Palella FJ , Delaney KM , Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
2. 2 Katlama C , Esposito R , Gatell JM et al. Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1. AIDS 2007; 21: 395-402.
3. 3 Haubrich R , Berger D , Chiliade P et al. Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients. AIDS 2007; 21: F11-F18.
4. 4 Clotet B , Bellos N , Molina JM et al. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. Lancet 2007; 369: 1168-1178.
5. 5 Gulick RM. New antiretroviral drugs. Clin Microbiol Infect 2003; 9: 186-193.
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HIV and Dyslipidemia;Contemporary Cardiology;2020-12-16
2. Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats;Reproductive Toxicology;2018-08
3. Effects of antiretroviral combination therapies F/TAF, E/C/F/TAF and R/F/TAF on insulin resistance in healthy volunteers: The TAF-IR Study;Antiviral Therapy;2018
4. Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV‐1‐infected subjects with dyslipidaemia;HIV Medicine;2017-07-03
5. HIV infection does not prevent the metabolic benefits of diet-induced weight loss in women with obesity;Obesity;2017-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3